Neonatal Estimation Of Brain Damage Risk And Identification of Neuroprotectants
NCT ID: NCT00544895
Last Updated: 2011-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
600 participants
OBSERVATIONAL
2007-10-31
2010-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Structural Brain Abnormalities in Children Born Prematurely: New Detection Methods and Clinical-Pathological Correlates
NCT00153855
Brain Activity During Birth for Prediction of Newborns at Risk for Brain Injury
NCT02445417
The Neu-Prem Trial: Neuromonitoring of Preterm Newborn Brain During Birth Resuscitation
NCT02605733
European Newborn Study: Early Markers for a Better LifE
NCT07189494
Neonatal Precursors of Neurodevelopment
NCT04703010
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Commission
OTHER
Hannover Medical School
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Perinatal Infectious Disease Epidemiology Unit - Medical School Hannover
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olaf Dammann
Role: STUDY_DIRECTOR
Medical School Hannover
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medizinische Universität Innsbruck
Innsbruck, , Austria
Hôpital Robert Debré
Paris, , France
Charité, Campus Virchow Klinikum
Berlin, , Germany
Universität Duisburg-Essen
Essen, , Germany
Hannover Medical School
Hanover, , Germany
Fondazione I.R.C.C.S Ospedale Maggiore Policlinico MA.RE.
Milan, , Italy
Azienda Ospedaliera Universitaria Senese
Siena, , Italy
Wilhelmina Children's Hospital
Utrecht, , Netherlands
Perinatal Center
Gothenburg, , Sweden
University Hospital
Lund, , Sweden
Academic Children's Hospital
Uppsala, , Sweden
Hôpital des Enfants
Geneva, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Dammann O, Cesario A, Hallen M. NEOBRAIN--an EU-funded project committed to protect the newborn brain. Neonatology. 2007;92(4):217-8. doi: 10.1159/000102967. Epub 2007 May 21. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LSHM-CT-2006-036534
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.